News

Published on 10 May 2024 on Simply Wall St. via Yahoo Finance

MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year


Article preview image

When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right business to buy shares in, you can make more than you can lose. For example, the MorphoSys AG (ETR:MOR) share price has soared 228% in the last 1 year. Most would be very happy with that, especially in just one year! We note the stock price is up 1.4% in the last seven days. The longer term returns have not been as good, with the stock price only 0.5% higher than it was three years ago.

So let's assess the underlying fundamentals over the last 1 year and see if they've moved in lock-step with shareholder returns.

NASDAQ.MOR price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year

When you buy shares in a company, there is always a risk that the price drops to zero. But if you...

Simply Wall St. via Yahoo Finance 10 May 2024

MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript

MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript March 14, 2024 MorphoSys AG isn't one ...

Insider Monkey via Yahoo Finance 15 Mar 2024

MorphoSys AG Unsponsored ADR (MOR) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 4 Mar 2024

What Makes MorphoSys AG Unsponsored ADR (MOR) a Strong Momentum Stock: Buy Now?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 15 Feb 2024

30 Countries with Highest Standard of Living Ranked by GDP (PPP) Per Capita

In this article, we will look into the 30 countries with highest standard of living ranked by GDP...

Insider Monkey via Yahoo Finance 14 Feb 2024

Germany stocks lower at close of trade; DAX down 0.95% By Investing.com

Germany stocks lower at close of trade; DAX down 0.95%

Investing.com 14 Feb 2024

Gilead (GILD) to Buy CBAY for $4.3B, Add PBC Drug to Pipeline

Gilead Sciences, Inc. GILD announced that it will acquire clinical-stage biopharmaceutical compan...

Zacks via Yahoo Finance 13 Feb 2024

Deal Watch: Wachtell, Paul Weiss and V&E Lead $26B Oil Merger as Deal Activity Soars | The American...

Energy and life sciences continue to lead the way in deal activity, but tech and other recently...

Law.com 12 Feb 2024

Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals

The fourth-quarter earnings season entered its last lap this week, with Eli Lilly LLY and AstraZe...

Zacks via Yahoo Finance 9 Feb 2024

Novartis To Acquire MorphoSys AG

The agreement, which is still subject to closing conditions, says that Novartis will pay about $7...

Pharmaceutical Executive Magazine 7 Feb 2024